Back
Innate Pharma SA Quote, Financials, Valuation and Earnings
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Buy
56
IPHYF
Innate Pharma SA
Last Price:
2.65
Seasonality Move:
1.38%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!Innate Pharma SA Price Quote
$2.65
Innate Pharma SA Key Stats
Buy
56
Innate Pharma SA (IPHYF)
is a Buy
Day range:
$2.65 - $2.65
52-week range:
$2.30 - $3.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.78
P/B ratio:
3.73%
Volume:
0
Avg. volume:
47
1-year change:
-7.99%
Market cap:
$214.2M
Revenue:
$56.2M
EPS:
$-0.1
How Much Does Innate Pharma SA Make?
-
How Much Are Innate Pharma SA's Sales Annually?
IPHYF Revenues are $56.2M -
How Much Profit Does Innate Pharma SA's Make A Year?
IPHYF net income is -$8.2M
Is Innate Pharma SA Growing As A Company?
Data Unavailable
Innate Pharma SA Stock Price Performance
-
Did Innate Pharma SA Stock Go Up Last Month?
Innate Pharma SA share price went up by 2.71% last month -
Did IPHYF's Share Price Rise Over The Last Year?
IPHYF share price fell by -7.99% over the past 1 year
What Is Innate Pharma SA 52-Week High & Low?
-
What Is Innate Pharma SA’s 52-Week High Share Price?
Innate Pharma SA has traded as high as $3.37 over the past 52 weeks -
What Is Innate Pharma SA’s 52-Week Low Share Price?
Innate Pharma SA has traded as low as $2.30 over the past 52 weeks
Innate Pharma SA Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Innate Pharma SA?
-
How Much Debt Does Innate Pharma SA Have?
Total long term debt quarterly is $43.2M -
How Much Cash Does Innate Pharma SA Have?
Cash and short term investments quarterly total is $102.2M -
What Is Innate Pharma SA’s Book Value Per Share?
Book value per share is 0.71
Is Innate Pharma SA Cash Flow Positive?
-
What Is IPHYF Cash Flow From Operations?
Cash flow from operations (TTM) is -$35.2M -
What Is Innate Pharma SA’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2.1M -
What Is Innate Pharma SA’s Cash Flow From Investing?
Cash flow from investing (TTM) is $22.2M
Innate Pharma SA Return On Invested Capital
-
Is Management Doing A Good Job?
IPHYF return on invested capital is -7.88% -
What Is Innate Pharma SA Return On Assets?
ROA measures how assets are converting to revenues and is -3.79% -
What Is IPHYF Return On Equity?
ROE is a measure of profitability and is -13.68%
Innate Pharma SA Earnings Date & Stock Price
-
What Is Innate Pharma SA's Stock Price Today?
A single share of IPHYF can be purchased today for 2.65 -
What Is Innate Pharma SA’s Stock Symbol?
Innate Pharma SA trades on the otcm under the ticker symbol: IPHYF -
When Is Innate Pharma SA’s Next Earnings Date?
The next quarterly earnings date for Innate Pharma SA is scheduled on September 12, 2024 -
When Is IPHYF's next ex-dividend date?
Innate Pharma SA's next ex-dividend date is May 2, 2024 -
How To Buy Innate Pharma SA Stock?
You can buy Innate Pharma SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Innate Pharma SA Competitors
-
Who Are Innate Pharma SA's Competitors?
Below is a list of companies who compete with Innate Pharma SA or are related in some way:
Innate Pharma SA Dividend Yield
Data Unavailable
Innate Pharma SA Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |